Startup profile · funding coverage
MIND funding, valuation and investors
AI-native data loss prevention that discovers, classifies, and blocks sensitive data across SaaS, GenAI, agents, and endpoints.
Verified company research · funding, investors and latest developments
Keep track of MIND
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series B
$72M · September 2026
Latest known valuation
~$300M (Ctech / company sources)
Series B · September 2026
Total disclosed equity funding
$102M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
series b · Seattle, USA
Investors in latest funding
Lead: Crosspoint Capital Partners
Other: YL Ventures , Paladin Capital Group
Overview
MIND (mind.io) builds Stress Free DLP and AI DLP Agents for enterprises that need to adopt GenAI without leaking PHI, IP, or regulated content. Seattle-headquartered with Israeli R&D, the company was founded by Hexadite co-founder Eran Barak and teammates from Torq, Axonius, and Unit 8200 pedigrees.
On September 17, 2026 it announced a $72M Series B led by Crosspoint Capital Partners with YL Ventures and Paladin Capital Group, bringing total funding to $112M. Company PR claims 17× revenue and 8× customer growth; Ctech separately attributed a ~$300M valuation and ~$10M ARR run rate to company sources.
Why MIND is interesting
September 2026 Series B put $72M behind a DLP rewrite for GenAI channels, with Children’s Hospital LA and National Geographic named as buyers — Crosspoint led as cyber specialists, not a generalist SaaS check.
Product & use cases
AI-native DLP and insider-risk platform: multi-layer classification, autonomous investigation/remediation agents, and policy-driven blocking across SaaS, GenAI, agentic AI, endpoints, file shares, and email.
- Block PHI and regulated data from entering GenAI tools on endpoints
- Label and restrict sensitive documents while monitoring AI-agent access
- Autopilot day-to-day DLP operations for lean security teams
Key facts
- Series B (Sep 2026): $72M led by Crosspoint; $112M total (company)
- Named customers: Children’s Hospital Los Angeles, National Geographic Society
- Ctech (company sources): ~$300M valuation; ~$10M ARR run rate — not in company PR
Funding history (newest first)
Series B
2026-09 $72M Valuation: ~$300M (Ctech / company sources)- Crosspoint Capital Partners (lead)
- YL Ventures (participant)
- Paladin Capital Group (participant)
Source: Read source · prnewswire.com
Series A
2025 $30M- Paladin Capital Group (lead)
- YL Ventures (participant)
- Crosspoint Capital Partners (participant)
Source: Read source · calcalistech.com
Market / IPO context
Editorial / static context — not a live quote.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.